Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
The Serum Institute of India (SII) is set to manufacture clinical trial doses of an experimental Ebola vaccine being developed by the University of Oxford, after the Coalition for Epidemic Preparedness Innovations (CEPI) announced fresh funding to …